November 17, 2025

Universal Health Services, Inc. (UHS) Stock Analysis: A Look at the Healthcare Giant’s Growth Potential and Market Position

Investors with an interest in the healthcare sector might find Universal Health Services, Inc. (NYSE: UHS) a compelling addition to their portfolios. With a market capitalization..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is making waves in the biotechnology sector with its promising growth trajectory and a substantial 26.17% potential..

Royalty Pharma plc (RPRX) Stock Analysis: 16% Upside Potential Captures Investor Interest

Royalty Pharma plc (NASDAQ: RPRX) sits at a unique intersection of finance and healthcare, offering investors a distinctive opportunity to engage with the biopharmaceutical sector. With..

Novartis AG (NVS) Stock Analysis: Strong ROE and Solid Dividend Yield Amidst Market Volatility

Novartis AG (NVS) stands as a formidable player in the global healthcare sector, with a market capitalization of $254.27 billion, making it one of the leading..

Becton, Dickinson and Company (BDX): Investor Outlook on a Healthcare Giant with a 4.38% Upside

Becton, Dickinson and Company (NYSE: BDX) stands as a colossus in the healthcare sector, specializing in medical instruments and supplies, with a sprawling portfolio that caters..

Haleon plc (HLN) Stock Analysis: Exploring a Potential 20% Upside for Investors in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, captures the spotlight with an intriguing investment..

Qiagen N.V. (QGEN) Stock Analysis: A 14.59% Potential Upside in the Healthcare Sector

Qiagen N.V. (QGEN) is making waves in the healthcare sector with its innovative approach to diagnostics and research. Headquartered in Venlo, Netherlands, Qiagen specializes in providing..

Humana Inc. (HUM) Stock Analysis: Exploring a 21.65% Upside Potential Amidst Healthcare Growth

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare plans industry, boasting a market capitalization of $28.52 billion. As a pivotal entity within..

McKesson Corporation (MCK) Stock Analysis: A Defensive Play with Growth Potential and a 10.36% Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is an intriguing proposition for investors seeking both stability and growth potential. With a market capitalization..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 22.64% Upside in Healthcare Innovation

Alcon Inc. (NYSE: ALC), a prominent player in the medical instruments and supplies sector, is capturing investor attention with a robust market cap of $38.71 billion..

ICON plc (ICLR) Stock Analysis: Evaluating a 27% Upside Potential in the Healthcare Sector

Investors interested in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing prospect. This Dublin-based clinical research organization, with a market cap of $12.48..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring the 17.98% Upside Potential

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector, continues to draw investor attention with its promising upside potential of 17.98%. Operating as a health..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 9% Potential Upside Amidst Healthcare Innovations

Teva Pharmaceutical Industries Limited (TEVA), a key player in the global pharmaceutical landscape, is drawing significant attention from investors. This Israel-based healthcare giant, known for its..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 7.62% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) continues to capture significant attention within the biotechnology sector, driven by its innovative approach and robust pipeline. With a market capitalization..

Genmab A/S (GMAB) Stock Analysis: A Promising 23% Potential Upside in the Biotech Sector

Genmab A/S (GMAB), a leading player in the biotechnology sector based in Denmark, is attracting attention from investors with its robust growth potential and strategic collaborations...

Bristol-Myers Squibb (BMY) Investor Outlook: Exploring a 13% Potential Upside Amid Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a prominent player in the healthcare sector, operates at the forefront of the biopharmaceutical industry. With a market capitalization of $99..

Veeva Systems Inc. (VEEV) Stock Analysis: A Promising 9.24% Upside for Healthcare Tech Investors

Investors in Veeva Systems Inc. (NYSE: VEEV) have much to consider as the company continues to carve out a significant niche in the healthcare technology sector...

Insmed Incorporated (INSM) Stock Analysis: Exploring the High Potential in Rare Disease Treatments with an Upside of Nearly 8%

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is making waves with its robust development pipeline targeting serious and rare diseases. With a..

Centene Corporation (CNC) Stock Analysis: Navigating a 21.5% Revenue Growth Amidst Healthcare Sector Challenges

Centene Corporation (NYSE: CNC) stands as a significant player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $17.88 billion,..

Incyte Corporation (INCY) Stock Analysis: A Healthcare Powerhouse with Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, continues to capture investor attention with its impressive revenue growth and extensive range of therapeutics...

Search

Funds

November 17, 2025

Search

Funds

November 17, 2025

FTSE 100

Funds